(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -216.90%-1.96M | -619K |
Payments to suppliers for goods and services | -216.90%-1.96M | ---619K |
Direct interest received | --202.81K | ---- |
Operating cash flow | -184.14%-1.76M | ---619K |
Investing cash flow | ||
Cash flow from continuing investing activities | -14,656.72%-1.68M | -11.38K |
Capital expenditure reported | ---1.67M | ---- |
Net PPE purchase and sale | -644.22%-84.69K | ---11.38K |
Net other investing changes | --74.17K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -14,656.72%-1.68M | ---11.38K |
Financing cash flow | ||
Cash flow from continuing financing activities | -105.05%-404.14K | 8M |
Net issuance payments of debt | --42.9K | ---- |
Net common stock issuance | ---447.04K | ---- |
Net other financing activities | ---- | --8M |
Cash from discontinued financing activities | ||
Financing cash flow | -105.05%-404.14K | --8M |
Net cash flow | ||
Beginning cash position | 1,128.93%8.02M | --652.8K |
Current changes in cash | -152.14%-3.84M | --7.37M |
Effect of exchange rate changes | ---29.13K | ---- |
End cash Position | -48.26%4.15M | --8.02M |
Free cash from | -457.17%-3.51M | ---630.38K |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data